Neurogene (NGNE) Institutional Ownership → Elon’s New A.I. Device is About to Shock the World (From InvestorPlace) (Ad) Free NGNE Stock Alerts $32.83 +2.87 (+9.58%) (As of 03:08 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Neurogene (NASDAQ:NGNE)CurrentInstitutional OwnershipPercentage52.37%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$28.78MNumber ofInstitutional Sellers(last 12 months)0 Get NGNE Insider Trade Alerts Want to know when executives and insiders are buying or selling Neurogene stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad InvestorPlaceHave You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat... Neurogene Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/15/2024Great Point Partners LLC994,229$19.27M3.3%N/A42.326% 2/14/2024Avidity Partners Management LP466,243$9.04M0.3%N/A19.840% 2/2/2024 BML Capital Management LLC24,666$478K0.4%N/A1.050% (Data available from 1/1/2016 forward) NGNE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NGNE shares? During the previous two years, the following institutional investors and hedge funds held shares of Neurogene shares: Great Point Partners LLC ($19.27M), and Avidity Partners Management LP ($9.04M), BML Capital Management LLC ($478K).Learn more on NGNE's institutional investors. What percentage of Neurogene stock is owned by institutional investors? 52.37% of Neurogene stock is owned by institutional investors. Learn more on NGNE's institutional investor holdings. Which institutional investors have been buying Neurogene stock? The following institutional investors have purchased Neurogene stock in the last 24 months: Great Point Partners LLC ($994.23K), Avidity Partners Management LP ($466.24K), and BML Capital Management LLC ($24.67K). How much institutional buying is happening at Neurogene? Institutional investors have bought a total of 1,485,138 shares in the last 24 months. This purchase volume represents approximately $28.78M in transactions. Related Companies: ORGO Major Shareholders HRTX Major Shareholders BMEA Major Shareholders ADCT Major Shareholders CRBP Major Shareholders IGMS Major Shareholders MRSN Major Shareholders RVNC Major Shareholders CDMO Major Shareholders TRDA Major Shareholders This page (NASDAQ:NGNE) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurogene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.